Literature DB >> 19675577

PPARδ activation promotes stratum corneum formation and epidermal permeability barrier development during late gestation.

Yan J Jiang1, Grant Barish, Biao Lu, Ronald M Evans, Debra Crumrine, Matthias Schmuth, Peter M Elias, Kenneth R Feingold.   

Abstract

The goal of epidermal ontogenesis is to form a stratum corneum (SC), which is required for post-natal permeability barrier function. The regulation of epidermal ontogenesis is poorly understood, but nuclear hormone receptors have been shown to have an important function. As peroxisome proliferator-activated receptor-delta (PPARdelta) is very abundant in fetal epidermis and PPARdelta activation stimulates differentiation and permeability barrier formation in adults, we hypothesized that PPARdelta might regulate epidermal ontogenesis. Treatment of fetal rat explants with the PPARdelta ligand, GW 610742X, accelerates permeability barrier development, evidenced by a decrease in transepidermal water loss and an enhanced outside-in barrier function, attributable to the presence of more mature lamellar membranes in the SC and enhanced expression of loricrin and involucrin. Similarly, the intra-amniotic administration of GW 610742X also accelerates the formation of the SC and permeability barrier development. Finally, in PPARdelta-deficient mice the formation of the SC and the expression of differentiation-related proteins were delayed on days 16.5 and 17.5 of gestation. However, at later stages (day 18.5 and after birth), there were no differences between wild-type- and PPARdelta-deficient mice, indicating only a transient delay in epidermal ontogenesis. These studies show that PPARdelta has a role in SC formation and permeability barrier development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675577     DOI: 10.1038/jid.2009.245

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  7 in total

1.  2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation.

Authors:  Carrie Hayes Sutter; Sridevi Bodreddigari; Christina Campion; Ryan S Wible; Thomas R Sutter
Journal:  Toxicol Sci       Date:  2011-08-11       Impact factor: 4.849

Review 2.  The role of barrier genes in epidermal malignancy.

Authors:  C Darido; S R Georgy; S M Jane
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

3.  Regulation of ABCG1 expression in human keratinocytes and murine epidermis.

Authors:  Yan J Jiang; Biao Lu; Elizabeth J Tarling; Peggy Kim; M-Q Man; Debbie Crumrine; Peter A Edwards; Peter M Elias; Kenneth R Feingold
Journal:  J Lipid Res       Date:  2010-08-01       Impact factor: 5.922

4.  Cooperative Synthesis of Ultra Long-Chain Fatty Acid and Ceramide during Keratinocyte Differentiation.

Authors:  Yukiko Mizutani; Hui Sun; Yusuke Ohno; Takayuki Sassa; Takeshi Wakashima; Mari Obara; Kohei Yuyama; Akio Kihara; Yasuyuki Igarashi
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

Review 5.  Lipolysis - a highly regulated multi-enzyme complex mediates the catabolism of cellular fat stores.

Authors:  Achim Lass; Robert Zimmermann; Monika Oberer; Rudolf Zechner
Journal:  Prog Lipid Res       Date:  2010-11-16       Impact factor: 16.195

6.  The polarity protein Scrib mediates epidermal development and exerts a tumor suppressive function during skin carcinogenesis.

Authors:  Helen B Pearson; Edwina McGlinn; Toby J Phesse; Holger Schlüter; Anuratha Srikumar; Nathan J Gödde; Christina B Woelwer; Andrew Ryan; Wayne A Phillips; Matthias Ernst; Pritinder Kaur; Patrick Humbert
Journal:  Mol Cancer       Date:  2015-09-17       Impact factor: 27.401

7.  Transcript profiling identifies dynamic gene expression patterns and an important role for Nrf2/Keap1 pathway in the developing mouse esophagus.

Authors:  Hao Chen; Jianying Li; Haiyan Li; Yuhui Hu; Whitney Tevebaugh; Masayuki Yamamoto; Jianwen Que; Xiaoxin Chen
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.